maladies – SLA et soutien aux biotechs françaises

This written question concerns the state of support and services provided to French biotechnology companies. It seeks to understand the current landscape of assistance available to these innovative firms. The question highlights the importance of the biotech sector for economic growth and innovation. It aims to identify potential areas for improvement in governmental support mechanisms.